# Alternative in Beta Blocker Intolerance: The ABBI Trial

> **NCT00893984** · PHASE4 · TERMINATED · sponsor: **Minneapolis Heart Institute Foundation** · enrollment: 6 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DRUG:** Nebivolol

## Key facts

- **NCT ID:** NCT00893984
- **Lead sponsor:** Minneapolis Heart Institute Foundation
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-05
- **Primary completion:** 2012-06
- **Final completion:** 2012-06
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Lack of patient recruitment
- **Last updated:** 2019-08-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00893984

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00893984, "Alternative in Beta Blocker Intolerance: The ABBI Trial". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00893984. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*